JP2014518880A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518880A5
JP2014518880A5 JP2014512134A JP2014512134A JP2014518880A5 JP 2014518880 A5 JP2014518880 A5 JP 2014518880A5 JP 2014512134 A JP2014512134 A JP 2014512134A JP 2014512134 A JP2014512134 A JP 2014512134A JP 2014518880 A5 JP2014518880 A5 JP 2014518880A5
Authority
JP
Japan
Prior art keywords
receptor
inhibitors
pirfenidone
fvc
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014512134A
Other languages
English (en)
Japanese (ja)
Other versions
JP6170040B2 (ja
JP2014518880A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/039538 external-priority patent/WO2012162592A1/en
Publication of JP2014518880A publication Critical patent/JP2014518880A/ja
Publication of JP2014518880A5 publication Critical patent/JP2014518880A5/ja
Application granted granted Critical
Publication of JP6170040B2 publication Critical patent/JP6170040B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014512134A 2011-05-25 2012-05-25 ピルフェニドン及び選択された患者における抗線維化療法 Expired - Fee Related JP6170040B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201161489936P 2011-05-25 2011-05-25
US61/489,936 2011-05-25
US201161490057P 2011-05-26 2011-05-26
US61/490,057 2011-05-26
US201161523047P 2011-08-12 2011-08-12
US61/523,047 2011-08-12
US201161524961P 2011-08-18 2011-08-18
US61/524,961 2011-08-18
PCT/US2012/039538 WO2012162592A1 (en) 2011-05-25 2012-05-25 Pirfenidone and anti-fibrotic therapy in selected patients

Publications (3)

Publication Number Publication Date
JP2014518880A JP2014518880A (ja) 2014-08-07
JP2014518880A5 true JP2014518880A5 (cg-RX-API-DMAC7.html) 2015-07-02
JP6170040B2 JP6170040B2 (ja) 2017-07-26

Family

ID=47217770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014512134A Expired - Fee Related JP6170040B2 (ja) 2011-05-25 2012-05-25 ピルフェニドン及び選択された患者における抗線維化療法

Country Status (11)

Country Link
US (1) US20150164874A1 (cg-RX-API-DMAC7.html)
EP (1) EP2713732A4 (cg-RX-API-DMAC7.html)
JP (1) JP6170040B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140022048A (cg-RX-API-DMAC7.html)
AU (1) AU2012258575B2 (cg-RX-API-DMAC7.html)
CA (1) CA2835438A1 (cg-RX-API-DMAC7.html)
HK (1) HK1197159A1 (cg-RX-API-DMAC7.html)
IL (1) IL229226A0 (cg-RX-API-DMAC7.html)
MX (1) MX2013013752A (cg-RX-API-DMAC7.html)
SG (1) SG195110A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012162592A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008265595B2 (en) 2007-06-20 2014-12-04 PureTech LYT 100 Inc. Substituted N-Aryl pyridinones as fibrotic inhibitors
BR112013022766A2 (pt) * 2011-03-08 2016-12-06 Auspex Pharmaceuticals Inc método de administração de d-pirfenidona e kit
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CA3280124A1 (en) 2013-07-31 2025-10-31 Avalyn Pharma Inc. Aerosol imatinib compounds and uses thereof
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
EP3194446B1 (en) * 2014-09-18 2022-10-26 Cedars-Sinai Medical Center Compositions and methods for treating fibrosis
DK3050574T3 (da) * 2015-01-28 2020-01-20 Univ Bordeaux Anvendelse af plerixafor til behandling og/eller forebyggelse af akutte forværringer af kronisk obstruktiv lungesygdom
US20180064662A1 (en) * 2015-03-05 2018-03-08 The General Hospital Corporation Novel compositions and uses of metformin agents
SG11201907673YA (en) * 2017-03-13 2019-09-27 Genfit Pharmaceutical compositions for combination therapy
US20210363259A1 (en) * 2017-08-22 2021-11-25 Biogen Ma Inc. Pharmaceutical compositions and dosage regimens containing anti-alpha(v)beta(6) antibodies
CA3140129A1 (en) * 2019-05-17 2020-11-26 The Regents Of The University Of California Mps modified peptides and use thereof
CN112239507A (zh) 2019-07-17 2021-01-19 鸿运华宁(杭州)生物医药有限公司 ETA抗体与TGF-β Trap的融合蛋白质,以及其药物组合物和应用
EP3821946A1 (en) * 2019-11-12 2021-05-19 Université de Strasbourg Anti-claudin-1 monoclonal antibodies for the prevention and treatment of fibrotic diseases
WO2021110805A1 (en) 2019-12-04 2021-06-10 Idorsia Pharmaceuticals Ltd Combination of an azetidine lpa1 receptor antagonist with pirfenidone and/or nintedanib for use in the treatment of fibrotic diseases
US20230129866A1 (en) * 2020-03-13 2023-04-27 Puretech Lyt 100, Inc. Methods of treating respiratory disease with deupirfenidone
CN114617890A (zh) * 2020-12-08 2022-06-14 四川夏派森医药科技有限公司 DH404在治疗SARS-CoV-2感染中的应用
CN112640887B (zh) * 2020-12-25 2022-05-13 武汉睿健医药科技有限公司 一种神经干细胞冻存液及其应用
WO2022266370A1 (en) * 2021-06-17 2022-12-22 Aria Pharmaceuticals, Inc. Sparsentan for treating idiopathic pulmonary fibrosis
CN114097807B (zh) * 2021-11-25 2023-05-05 兰州大学 巴多索隆类化合物在抗农业病原真菌中的用途
WO2023192646A1 (en) * 2022-03-31 2023-10-05 Puretech Lyt 100, Inc. Methods of treating fibrotic- and collagen-mediated diseases and disorders with deupirfenidone

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE420878T1 (de) * 2000-02-18 2009-01-15 Kyowa Hakko Kirin Co Ltd Isoxazol- und thiazolverbindungen und ihre verwendung als medikamente
CN1307997C (zh) * 2002-06-28 2007-04-04 图兰恩教育基金管理人 用于治疗肺纤维化的4-(4-甲基哌嗪-1-基甲基)-n-[4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯基]-苯甲酰胺
WO2004103296A2 (en) * 2003-05-16 2004-12-02 Intermune, Inc. Methods of treating idiopathic pulmonary fibrosis
WO2005110478A2 (en) * 2004-04-13 2005-11-24 Intermune, Inc. Combination therapy for treating fibrotic disorders
WO2007119214A2 (en) * 2006-04-13 2007-10-25 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
HUE052220T2 (hu) * 2006-09-08 2021-04-28 Abbvie Bahamas Ltd Interleukin-13 kötõfehérjék
AU2008265595B2 (en) * 2007-06-20 2014-12-04 PureTech LYT 100 Inc. Substituted N-Aryl pyridinones as fibrotic inhibitors
EP2389227A4 (en) * 2009-01-26 2012-08-08 Intermune Inc METHOD FOR THE TREATMENT OF ACUTE MYOCARDINE CARDS AND ASSOCIATED ILLNESSES THEREOF
GB2474748B (en) * 2009-10-01 2011-10-12 Amira Pharmaceuticals Inc Polycyclic compounds as lysophosphatidic acid receptor antagonists

Similar Documents

Publication Publication Date Title
JP6170040B2 (ja) ピルフェニドン及び選択された患者における抗線維化療法
KR102293847B1 (ko) 근위축성 측색 경화증 환자 아집단의 치료를 위한 마시티닙의 용도
AU2019204938B2 (en) Mdm2 inhibitors and combinations thereof
JP7196169B2 (ja) 進行性線維化を伴う間質性肺疾患(pf-ild)の処置のための活性剤の新規組み合わせ
US20130123272A1 (en) Organic compound for use in the treatment of liver cancer
MXPA06008157A (es) Tratamiento de gliomas malignos con inhibidores de factor de crecimiento transformante-beta.
RS67920B1 (sr) Ripretinib za lečenje gastrointestinalnih stromalnih tumora
RU2007146390A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
MX2015001627A (es) Terapia de combinacion para el tratamiento de glioblastoma.
CN112055584A (zh) sGC活化剂和sGC刺激剂用于治疗认知障碍的用途
WO2016193955A1 (en) Combinations of kinase inhibitors for treating colorectal cancer
CA3260897A1 (en) Polytherapy based on a tyrosine kinase inhibitor and a type 2 activin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH)
JP2022500485A (ja) グラピプラント単位剤形
Kanesvaran et al. A single-arm phase 1b study of everolimus and sunitinib in patients with advanced renal cell carcinoma
Chuang et al. A phase I clinical trial of trametinib in combination with TAS-102 in patients with chemotherapy-resistant RAS-mutated (PIK3CA/PTEN-wild type) metastatic colorectal cancer
TWI656876B (zh) 治療pah之抗增生劑
CN118302167A (zh) 用于治疗进行性纤维化间质性肺病的新颖口服药物组合物及剂量方案
Berenson et al. A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma
WO2014151517A1 (en) Methods of improving microvascular integrity
JP2019513727A (ja) レンバチニブ及びエベロリムスを用いた腎細胞癌の治療
JP2005516993A (ja) 神経芽細胞腫の処置
NZ617415B2 (en) Pirfenidone and anti-fibrotic therapy in selected patients
HK1261581B (en) Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation